1. Male, female, or X (non-binary gender) subjects, 18-55y inclusive on the day of signing of the ICF 2. Provision of signed and dated informed consent form 3. Available at all provided timepoints of the study and is not planning to move abroad for the whole duration of the study 4. In good general health as evidenced by medical history and/or physical examination or adults with pre-existing medical conditions who are in stable condition. A stable medical condition is defined as disease not requiring significant change in therapy or hospitalization for worsening disease during the 3 months before enrollment. 5. Willing and able to comply with all study procedures 6. Participants born female must be either: - of childbearing potential and using effective contraception for at least 1 month prior to screening and agree to use such a method during study participation until 1 months following the last study dose administration. - of non-childbearing potential.

1. Male, female, or X (non-binary gender) subjects, 18-55y inclusive on the day of signing of the ICF 2. Provision of signed and dated informed consent form 3. Available at all provided timepoints of the study and is not planning to move abroad for the whole duration of the study 4. In good general health as evidenced by medical history and/or physical examination or adults with pre-existing medical conditions who are in stable condition. A stable medical condition is defined as disease not requiring significant change in therapy or hospitalization for worsening disease during the 3 months before enrollment. 5. Willing and able to comply with all study procedures 6. Participants born female must be either: - of childbearing potential and using effective contraception for at least 1 month prior to screening and agree to use such a method during study participation until 1 months following the last study dose administration. - of non-childbearing potential.